Vasculitis Trial, Recruiting NCT06599411 Sponsor: Assistance Publique - Hôpitaux de Paris Condition: Vasculitis
Back to Vasculitis

Vasculitis Trial, Recruiting

NCT06599411
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

If you have a skin condition:

  • You are over 18 years old
  • You have given your written agreement to take part in the trial
  • You have been diagnosed with a moderate to severe long-term inflammatory skin condition (this includes: atopic dermatitis, psoriasis, hidradenitis suppurativa, lichen planus, cutaneous lupus, dermatomyositis, morphea, neutrophilic dermatosis, cutaneous granulomatosis, cutaneous vasculitis, or autoimmune blistering skin disease)
  • Alternatively, you have been diagnosed with an active form of leprosy (certain types are listed — excluding leprosy that only affects the nerves) (confirm with trial site)

If you are a healthy volunteer:

  • You are over 18 years old
  • You have recently had plastic surgery that produced healthy leftover skin tissue
  • You have given your written agreement to take part in the trial
  • You do not have any known inflammatory skin condition

Who may not be able to join:

  • You are under legal guardianship or a court-appointed protection order
  • You are currently pregnant or breastfeeding
  • You are not registered with a social security system (this appears to relate to French social security — confirm with trial site)
  • You are currently taking, or have taken in the last 3 months, any medication that suppresses or modifies your immune system, including steroid treatments

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 28 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Phone: 630944832

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Registry
ClinicalTrials.gov
Start date
20 October 2025
Est. completion
20 November 2035

Where this trial is recruiting

🇫🇷 France

Primary endpoints

Therapeutic response

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov